Last reviewed · How we verify
Iofetamine I 123 (Iofetamine (123I))
Iofetamine I 123 (generic name: Iofetamine (123I)) is a Iofetamine (123I) drug. It is currently in unknown development.
Iofetamine I 123 is a radioactive compound that binds to specific sites in the body, allowing for diagnostic imaging.
Iofetamine I 123 (Iofetamine (123I)) is a small molecule radiopharmaceutical drug of the iofetamine class. Its exact target and mechanism of action are unknown, but it is used for diagnostic purposes. The commercial status of Iofetamine I 123 is unclear, and it may be patented or have generic manufacturers. Iofetamine I 123 is not FDA-approved for any indications, and its half-life, bioavailability, and safety considerations are unknown. Further research is needed to fully understand this drug.
At a glance
| Generic name | Iofetamine (123I) |
|---|---|
| Drug class | Iofetamine (123I) |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine a special kind of dye that is attached to a tiny amount of radioactive material. When this dye is injected into the body, it travels to specific areas and binds to certain cells or tissues. This allows doctors to use a special camera to take pictures of the body and see where the dye has accumulated, which can help diagnose certain conditions.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iofetamine I 123 CI brief — competitive landscape report
- Iofetamine I 123 updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Iofetamine I 123
What is Iofetamine I 123?
How does Iofetamine I 123 work?
What is the generic name of Iofetamine I 123?
What drug class is Iofetamine I 123 in?
What development phase is Iofetamine I 123 in?
Related
- Drug class: All Iofetamine (123I) drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing